Neural Regeneration Research ›› 2016, Vol. 11 ›› Issue (7): 1090-1098.doi: 10.4103/1673-5374.187041

Previous Articles     Next Articles

Electroacupuncture alleviates cerebral ischemia and reperfusion injury via modulation of the ERK1/2 signaling pathway

Xiao-lu Jin1, #, Peng-fei Li2, #, Chun-bing Zhang2, 3, Jin-ping Wu3, Xi-lian Feng1, Ying Zhang1, Mei-hong Shen1, *   

  1. 1 Second Clinical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China 2 Department of Clinical Laboratory, Jiangsu Province Hospital of Traditional Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China 3 College of Basic Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China
  • Online:2016-07-30 Published:2016-07-30
  • Contact: Mei-hong Shen, Ph.D., 13815894855@163.com.
  • Supported by:
    This study was supported by the National Natural Science Foundation of China, No. 81373748, 81171659, 11574156 and 81403136; a grant from the 333 Project of Jiangsu Province in China No. BRA2014341; and a grant from the Jiangsu Province Science and Technology Support Project in China, No. BE2010769.

Abstract: Electroacupuncture (EA) has anti-oxidative and anti-inflammatory actions, but whether the neuroprotective effect of EA against cerebral ischemia-reperfusion (I/R) injury involves modulation of the extracellular regulated kinase 1/2 (ERK1/2) signaling pathway is unclear. Middle cerebral artery occlusion (MCAO) was performed in Sprague-Dawley rats for 2 hours followed by reperfusion for 24 hours. A 30-minute period of EA stimulation was applied to both Baihui (DU20) and Dazhui (DU14) acupoints in each rat (10 mm EA penetration depth, continuous wave with a frequency of 3 Hz, and a current intensity of 1–3 mA) when reperfusion was initiated. EA significantly reduced infarct volume, alleviated neuronal injury, and improved neurological function in rats with MCAO. Furthermore, high mRNA expression of Bax and low mRNA expression of Bcl-2 induced by MCAO was prevented by EA. EA substantially restored total glutathione reductase (GR), glutathione (GSH) and glutathione peroxidase (GSH-Px) levels. Additionally, Nrf2 and glutamylcysteine synthetase (GCS) expression levels were markedly increased by EA. Interestingly, the neuroprotective effects of EA were attenuated when ERK1/2 activity was blocked by PD98059 (a specific MEK inhibitor). Collectively, our findings indicate that activation of the ERK1/2 signaling pathway contributes to the neuroprotective effects of EA. Our study provides a better understanding of the regulatory mechanisms underlying the therapeutic effectiveness of EA.

Key words: "nerve regeneration, electroacupuncture, ischemia and reperfusion injury, middle cerebral artery occlusion, mitogen-activated protein kinase, oxidative stress, nuclear factor erythroid 2-related factor 2, glutamylcysteine synthetase, glutathione reductase, B cell lymphoma 2, glutathione peroxidase"